Profusa (NVACW) Net Income towards Common Stockholders (2022 - 2026)
Profusa posted quarterly Net Income towards Common Stockholders of -$4.0 million for Q1 2026, down 259.31% year-on-year from $2.5 million in Q1 2025, and up 13.43% on a QoQ basis from -$4.6 million in Q4 2025.
Profusa (NVACW) has 5 years of Net Income towards Common Stockholders data on file, last reported at -$4.0 million in Q1 2026.
- For the quarter ending Q1 2026, Net Income towards Common Stockholders fell 259.31% year-over-year to -$4.0 million; the trailing twelve-month figure through Mar 2026 stood at -$38.7 million (down 329.33% YoY), and the FY2025 full-year result was -$30.2 million, down 246.43% from the prior year.
- Net Income towards Common Stockholders for Q1 2026 stood at -$4.0 million, up from -$4.6 million in the prior quarter.
- Across five years, Net Income towards Common Stockholders topped out at $2.9 million in Q1 2022 and bottomed at -$21.9 million in Q3 2025.
- The 5-year median for Net Income towards Common Stockholders is -$397487.0 (2024), against an average of -$2.7 million.
- The widest annual swing landed in 2024, when Net Income towards Common Stockholders jumped 129.48%; it then plunged 24095.09% in 2025.
- A 5-year view of Net Income towards Common Stockholders shows it stood at -$3.7 million in 2022, then surged by 105.74% to $212692.0 in 2023, then tumbled by 3672.63% to -$7.6 million in 2024, then soared by 38.83% to -$4.6 million in 2025, then climbed by 13.43% to -$4.0 million in 2026.
- The last three Net Income towards Common Stockholders figures came in at -$4.0 million (Q1 2026), -$4.6 million (Q4 2025), and -$21.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 1.15 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 187,319.30 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 199.50 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Profusa | - | - | - | -4.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.02 Mn |
| Dec 31, 2025 | -3.65 Mn |
| Sep 30, 2025 | -21.88 Mn |
| Jun 30, 2025 | -8.20 Mn |
| Mar 31, 2025 | -1.12 Mn |
| Dec 31, 2024 | -7.59 Mn |
| Sep 30, 2024 | 91,177.00 |
| Jun 30, 2024 | -397,487.00 |
| Mar 31, 2024 | -820,277.00 |
| Dec 31, 2023 | 212,692.00 |
| Sep 30, 2023 | -309,328.00 |
| Jun 30, 2023 | 717,766.00 |
| Mar 31, 2023 | 104,235.00 |
| Dec 31, 2022 | 103,697.00 |
| Sep 30, 2022 | 379,035.00 |
| Jun 30, 2022 | 260,531.00 |
| Mar 31, 2022 | 797,050.00 |